ANNEXON
Live / Allowed — Notice of allowance issued (as of 13 May 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 12 Aug 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98694164
- Mark type
- Stylized text
- Filed
- 12 Aug 2024
- Published for opposition
- 18 Mar 2025
- Attorney of record
- Joshua S. Jarvis, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of immune system related diseases and disorders, complement-mediated diseases and disorders, neurological diseases and disorders, and ophthalmic diseases and disorders; pharmaceutical preparations for the treatment of Guillain-Barré syndrome, macular degeneration, geographic atrophy, Huntington's Disease, amyotrophic lateral sclerosis (ALS), lupus, cold agglutinin disease (CAD), chronic inflammatory demyelinating polyneuropathy (CIDP), and myasthenia gravis (MG).
- Class 042 — Scientific and technological services: Pharmaceutical research and development; consulting services in the field of pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials.
- Class 044 — Medical, beauty and agricultural services: Providing medical information; providing medical information related to pharmaceuticals.
Owner
- Annexon, Inc., Brisbane, CA, US
- Annexon, Inc., Brisbane, CA, US
Prosecution history
- 11 Sept 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 19 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 11 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 13 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Mar 2025 — PUBLISHED FOR OPPOSITION
- 12 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Feb 2025 — ASSIGNED TO EXAMINER
- 16 Jan 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 12 Aug 2024 — NEW APPLICATION ENTERED